Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Samuel So, MBBS, FACS, a globally recognized ...

(Web Desk) - Consuming moldy food, drinking alcohol, and reusing fried oil can place undue stress on the liver’s detoxification process, potentially increasing the risk of liver cancer over time.

The pivotal Phase II trial is testing Allogene’s CAR T candidate cemacabtagene ansegedleucel for large B-cell lymphoma.

Discover how lymphoid structures and germinal centers provide powerful prognostic insights into colorectal cancer.

Adam Wereszczynski was gobsmacked when tests revealed he had liver disease -he now wants to warn others about the dangers of ...

Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has ...

A group of Australian scientists has uncovered a new way to fight some of the toughest cancers by targeting an overlooked ...

Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its ...

In July 2025, Pfizer announced a study to establish baseline prospective efficacy data of current FIX prophylaxis replacement ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 30, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...